Reported Dec 9, 2015 · Terminated

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual…

Nephron Pharmaceuticals Corp.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Nephron Pharmaceuticals Corp. · 4121 SW 34th St · Orlando, FL · 32811-6475

Is this the product you have?

  • Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton
  • Manufactured Bynephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
Lot codes and dates
    • Lots R4016A (Exp 08/31/2015)
    • R4017A (Exp 08/31/2015)
    • R4035A (Exp 12/31/2015)
Amount recalled
32,490 cartons

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

Discoloration

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Nephron Pharmaceuticals Corp. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 10, 2017 · Data as of Sep 19, 5:00 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.